SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-22-012003
Filing Date
2022-03-28
Accepted
2022-03-28 17:13:38
Documents
5
Effectiveness Date
2022-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 atha-s8.htm S-8 167041
2 EX-5.1 atha-ex51_29.htm EX-5.1 9193
3 EX-23.1 atha-ex231_136.htm EX-23.1 2752
4 EX-FILING FEES atha-exfilingfees_137.htm EX-FILING FEES 71016
5 GRAPHIC g5jtohvkpucy000001.jpg GRAPHIC 125874
  Complete submission text file 0001564590-22-012003.txt   424479
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263907 | Film No.: 22776342
SIC: 2836 Biological Products, (No Diagnostic Substances)